AMGN 全部观点

已加载 4 条观点条目,其中 0 条方向发生变化

在已加载记录中筛选
《NVDA Fallout: Where Is the Smart Money Going? | Market Pulse Nov. 13, 2026》
$AMGN看涨
AI 摘要 · AMGN 的压缩弹簧图表形态是说话者预期上涨的理由,因为做市商会让它维持区间震荡后再向上推动;这一走势仍需要市场给出强劲推动。他指出,AMGN 在弱势市场中并未崩跌,称其是一只好股票,同时表示还要再看看。

那么让我来回顾一下 Amgen 的股票。我把图放大一些,好让你们看得更清楚。Amgen 的股票。看看这个。所以 Amgen 处于一种妥协状态,这就是我在上一个视频里谈到的。她谈到了 Apple 和 Amgen。

现在就是这样。箭头聚集起来,像一根被压缩的弹簧。在我看来,这根压缩的弹簧是上涨的理由,因为做市商会在把它向上拉升之前,先把它控制在一定区间内。我们拭目以待。它需要市场给出强有力的推动才能到那里,但它在这样疲弱的市场里并没有崩掉。这是只好股票,不是吗?

So let me review Amgen's stock. I'm going to enlarge the graph so you can see it a little more clearly. Amgen stock. Look at that. So Amgen is in a state of compromise, which is what I talked about in my last video.

She talked about Apple and Amgen. And here we are. The arrow gathers like a compressed spring. In my opinion, the compressed spring is a reason for the rise, because market makers keep it within a certain range before they jump it upwards.

We'll see. It needs a strong push from the market to get there, but it doesn't collapse in this weak market. It's a good stock, isn't it?

《AAPL & AMGN in the Buy Zone: 2 Stocks Ready to Break Out?》
$AMGN看涨
AI 摘要 · AMGN 处于买入区:在长期杯形底之上形成双底形态,突破已持续3周且未脱离买入区;股价位于50日、21日和200日均线之上,看起来像是一个有望上涨的早期底部。近期盈利增长14%(尚可,但不算亮眼),每股收益每年稳定增长7%,销售额每年增长12%(相当不错,但不算惊人),强度评级为84。说话者会在当前价位附近买入,并卖出略虚值的12月备兑看涨期权,权利金约3.2%。

第一只是 Amgen。所以我想在这里看一下 Amgen。Amgen 现在在周线上显示出一个,呃,周线级别的底部。我把它放大给你看。呃,在周线级别上,你可以看到它在一个双底形态之上处于买入区间。

而这个双底又位于这个杯形底部之上。所以这里有一个很大的长期整理底部。你可以看到它已经突破,而且过去 3 周一直在突破,但它还没有远离买入区间。这里这个小小的绿色区域就是买入区间。

The first one is Amgen. So, I want to look at Amgen here. And so Amgen right now is showing a um on a weekly on a weekly base. Let me blow this up for you. Uh on a weekly base, you can see it is in a buy zone here off a double bottom base.

And the double bottom bases on top of this cup base. So we've got a big long consolidation base right in here. And you can see it broke out and has been breaking out for the last 3 weeks, but it hasn't pulled away from the buy zone.

This little green zone right here is the buy zone.

David Lin 发布 2026-09-27
《‘Almost 0%’ Chance Stocks Are Higher In 10 Years | Bill Smead》
$AMGN看涨
AI 摘要 · 持有AMGN,看重其保守的会计处理——将收入的18-20%投入研发并当期费用化,而非资本化摊销。

我们持有 Merc 和 Amgen,我们喜欢这两家公司,因为它们的会计处理是所有大型公司中最保守的。我这话是什么意思?它们每年把收入的 18% 到 20% 投入研发,并在当期一次性计入费用。

计入费用。它们不做折旧摊销。这是它们所做的最重要的长期投资。所以,它们的利润表实际上比其他公司要赚钱得多,因为它们的会计处理如此保守。

we own Merc and Amgen, and we love those companies because they have the most conservative accounting of any major corporations. What do I mean by that? They spend 18 to 20% of of their revenue each year on R&D and expense it upfront.

Expense it. They don't depreciate. It's the most important long-term investment they make. So, their income statement, they are actually much more profitable as compared to other corporations because of how conservative their accounting is.

Wealthion发布 2026-09-18
《Mark Skousen: Why He's Still 100% Invested at All-Time Highs》
$AMGN看涨
AI 摘要 · 尽管下跌了8%,Amgen仍被推荐为道琼斯工业平均指数中的首选股票。

因此,在这方面,我推荐 Amgen 作为我在道琼斯工业平均指数中的首选股票。我看到 Amgen 的股价已经下跌了 8%。

Therefore, I recommend Amgen as my top stock in the Dow Jones Industrial Average in this regard. I see that Amgen's stock has fallen by 8%.

已经是最早的记录
其他股票的全部观点条目
把 $AMGN 加入我的股票30 天完整试用
开始试用